Linda S. Barton
South College(US)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Phytochemicals and Antioxidant Activities, Ion Channels and Receptors, Cell Adhesion Molecules Research, Platelet Disorders and Treatments, Peptidase Inhibition and Analysis
Most-Cited Works
- → Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptide(1993)90 cited
- → Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists(1996)72 cited
- → The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophore(2013)58 cited
- → Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4)(2019)52 cited
- → Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics(1999)30 cited
- → Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4)(2018)27 cited
- → Discovery of GSK3527497: A Candidate for the Inhibition of Transient Receptor Potential Vanilloid-4 (TRPV4)(2019)23 cited
- → Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening(2022)17 cited
- → Improving the developability profile of pyrrolidine progesterone receptor partial agonists(2009)12 cited
- → The development of an automated countercurrent chromatography process for isolation of anthocyanins(2018)6 cited